KÄÄPÄ Biotech

Raised $10.5M in a Strategic round, announced 13 November 2025.

Total raised
$10.5M

Latest round StrategicCountry FinlandSector Consumer

Round

$10.5MStrategic, 13 November 2025

Expands cultivation capacity, vertical integration and R&D for its NordRelease functional mushroom ingredients.

Amount
$10.5M
Stage
Strategic
Announced
13 November 2025
Lead
PeakBridge
Other investors
Zintinus
Use of funds
Expands cultivation capacity, vertical integration and R&D for its NordRelease functional mushroom ingredients.
Checked
Announced by the company
Source
KÄÄPÄ Biotech receives 9 million euro strategic investment from PeakBridge and Zintinus kauppalehti.fi
Newsletter Startup rounds, in your inbox.

Free. Unsubscribe anytime.

Company

Cultivates Nordic functional mushrooms and makes nutraceutical ingredients from them

Based in
Finland
Sector
Consumer
Website
kaapabiotech.com ↗

Links

Website
kaapabiotech.com ↗

Questions

How much has KÄÄPÄ Biotech raised?

KÄÄPÄ Biotech raised $10.5M in a Strategic round, announced on 13 November 2025.

Who invested in KÄÄPÄ Biotech?

PeakBridge led. Investors include PeakBridge and Zintinus.